Publications by authors named "Simon Lichtiger"

Claim this Profile
T
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
Bram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, Rebecca Mosig, Brian G Feagan, Simon Lichtiger

J Crohns Colitis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy, Safety, and Tolerability of 
Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
Andrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, Simon Lichtiger, Josep Bassaganya-Riera

Inflamm Bowel Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.
Andrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, Simon Lichtiger, Josep Bassaganya-Riera

Inflamm Bowel Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.
Adam S Faye, Aaron Oh, Lindsay D Kumble, Ravi P Kiran, Timothy Wen, Simon Lichtiger

Inflamm Bowel Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.
Adam S Faye, Timothy Wen, Ashwin N Ananthakrishnan, Simon Lichtiger, Gilaad G Kaplan

Clin Gastroenterol Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease.
Simon Lichtiger

Gastrointest Endosc Clin N Am· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.
Jordan E Axelrad, Andrew Joelson, Peter H R Green, Garrett Lawlor, Simon Lichtiger

Am J Gastroenterol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases.
Yael R Nobel, Jordan Axelrad, Suzanne K Lewis, Susan Whittier, Garrett Lawlor, Simon Lichtiger

Dig Dis Sci· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Crohn's Disease Anastomotic Stricture With a Lumen-apposing Metal Stent.
Jordan E Axelrad, Simon Lichtiger, Amrita Sethi

Clin Gastroenterol Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
Jordan E Axelrad, Andrew Joelson, Yael R Nobel, Garrett Lawlor, Peter H R Green, Simon Lichtiger

Inflamm Bowel Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
Jordan E Axelrad, Abhik Roy, Garrett Lawlor, Burton Korelitz, Simon Lichtiger

World J Gastroenterol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.
Jordan E Axelrad, Simon Lichtiger, Vijay Yajnik

World J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
Abhik Roy, Simon Lichtiger

Inflamm Bowel Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.
Gil Y Melmed, William M Pandak, Kevin Casey, Bincy Abraham, John Valentine, Simon Lichtiger

Inflamm Bowel Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Marc Ferrante, Jean-Frederic Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Simon Lichtiger

Gastroenterology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature.
David Hudesman, Simon Lichtiger, Bruce Sands

Inflamm Bowel Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.
Mark Lazarev, Daniel H Present, Simon Lichtiger, Asher Kornbluth, James Marion

J Clin Gastroenterol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Simon Lichtiger

N Engl J Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Simon Lichtiger

N Engl J Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine.
Simon Lichtiger

Inflamm Bowel Dis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
Elana A Maser, Deepthi Deconda, Simon Lichtiger, Thomas Ullman, Daniel H Present

Clin Gastroenterol Hepatol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.
Michael B Sternthal, Seamus J Murphy, James George, Asher Kornbluth, Simon Lichtiger

Am J Gastroenterol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis.
Arun Swaminath, Simon Lichtiger

Inflamm Bowel Dis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy.
Naris Nilubol, Ellen Scherl, David S Bub, Stephen R Gorfine, James Marion, Simon Lichtiger

Dis Colon Rectum· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Cyclosporine Therapy in Ulcerative Colitis Treatment.
Simon Lichtiger

Gastroenterol Hepatol (N Y)· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis